Chinook Therapeutics Inc

NASDAQ:KDNY   3:59:53 PM EDT
12.95
+0.06 (+0.46%)
Earnings Announcements

Chinook Therapeutics Provides Business Update And Reports Q2 Results

Published: 08/12/2021 22:05 GMT
Chinook Therapeutics Inc (KDNY) - Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results.
Chinook Therapeutics Inc - Qtrly Loss per Share $0.97.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.84

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.88

More details on our Analysts Page.